Draft amendments to India’s Drugs Rules would allow licensing authorities to immediately suspend manufacturers after a government analyst finds a medicine fails critical quality standards.
​Draft amendments to India’s Drugs Rules would allow licensing authorities to immediately suspend manufacturers after a government analyst finds a medicine fails critical quality standards.  by Soban News (international And National News)
